Government services provider Maximus (NYSE:MMS) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 4.1% year on year to $1.35 billion. The company’s full-year revenue guidance of $5.28 billion at the midpoint came in 3.6% below analysts’ estimates. Its non-GAAP profit of $1.85 per share was 1.6% above analysts’ consensus estimates.
Is now the time to buy MMS? Find out in our full research report (it’s free for active Edge members).
Maximus (MMS) Q4 CY2025 Highlights:
- Revenue: $1.35 billion vs analyst estimates of $1.37 billion (4.1% year-on-year decline, 2.2% miss)
- Adjusted EPS: $1.85 vs analyst estimates of $1.82 (1.6% beat)
- Adjusted EBITDA: $170.4 million vs analyst estimates of $172.4 million (12.7% margin, 1.2% miss)
- The company dropped its revenue guidance for the full year to $5.28 billion at the midpoint from $5.33 billion, a 0.9% decrease
- Management raised its full-year Adjusted EPS guidance to $8.20 at the midpoint, a 1.2% increase
- EBITDA guidance for the full year is $738 million at the midpoint, in line with analyst expectations
- Operating Margin: 10.9%, up from 6.2% in the same quarter last year
- Market Capitalization: $4.27 billion
StockStory’s Take
Maximus faced a challenging fourth quarter, as the market responded negatively to weaker-than-expected revenue and a lowered full-year revenue outlook. Management attributed the revenue decline primarily to delayed government contract awards and reduced volumes in its US Services and international segments. CEO Bruce Caswell noted that the temporary government shutdown led to slower payments and delays in award decisions, which hindered new project activity. The company also completed the divestiture of its child support business, shifting focus toward higher-value opportunities. Caswell emphasized, “Our first quarter results reflect virtually no direct impact to our contract portfolio from the shutdown last fall,” but acknowledged the knock-on effects of delayed awards and payments.
Looking ahead, Maximus expects its updated guidance to be driven by technology investments, particularly in automation and artificial intelligence, as well as emerging opportunities in Medicaid and SNAP (Supplemental Nutrition Assistance Program) support services. Management highlighted their recent launch of the AI-powered Accuracy Assistant tool, designed to help states reduce SNAP payment errors, and underscored the importance of upcoming Medicaid eligibility and community engagement requirements. CFO David Mutryn stated, “We continue to believe that [Medicaid and SNAP] could create a high single to low double-digit organic growth opportunity for US services… once fully ramped,” but cautioned that most new work will benefit results in 2027 and beyond.
Key Insights from Management’s Remarks
Management pointed to delayed contract awards and lower volumes in key segments as main reasons for the quarter’s revenue miss, while highlighting progress in technology-driven services.
- Delayed government contract awards: CEO Bruce Caswell explained that federal award activity was directly impacted by the government shutdown, causing a lighter-than-normal quarter for new business wins and a book-to-bill ratio of 0.2 times, well below historical norms. This was described as a timing issue rather than a structural change, with a rebound expected in subsequent quarters.
- US Services segment contraction: The US Services business experienced lower volumes across several programs, especially as states reduced demand for engagement and eligibility support compared to prior years. Management linked this to cyclical changes in Medicaid and other state-administered services, not to specific program failures.
- International headwinds and divestitures: The outside US segment saw lower revenues, largely attributable to the divestiture of the Australian and South Korean businesses. These moves were presented as part of a strategic effort to focus on higher-value markets, though they contributed to near-term revenue contraction and operating losses in the segment.
- Technology and AI investments: Maximus accelerated its shift toward technology-driven solutions, including new AI-powered tools for eligibility verification and document processing. Caswell highlighted recent AI deployments that improved case throughput and reduced error rates, citing a 45% autonomous resolution rate in certain dispute processes.
- SNAP program as growth opportunity: The launch of the Accuracy Assistant tool for SNAP payment error reduction was highlighted as a key new offering, with management reporting strong initial receptivity from state customers. This tool leverages predictive analytics and automation to address compliance requirements and is expected to open further business process service opportunities in the future.
Drivers of Future Performance
Maximus’s outlook centers on technology-driven service expansion, policy-driven demand in state programs, and the pace of government contract awards.
- Medicaid and SNAP policy changes: Management expects upcoming legislative requirements—such as twice-yearly Medicaid eligibility redeterminations and new SNAP payment error thresholds—to drive increased demand for its support services and technology tools. These policy shifts are anticipated to accelerate in 2027 and beyond, providing a foundation for future growth.
- Technology and automation adoption: The company is prioritizing investment in AI and automation to both improve operating margins and offer differentiated services to government clients. Caswell described Maximus as “customer zero” for its own AI tools, noting that successful internal adoption is supporting external market credibility.
- Award timing and pipeline conversion: Management cautioned that the timing of new contract awards remains uncertain, with current year guidance assuming minimal new work. CFO David Mutryn indicated that while the pipeline is growing, the realization of revenue from these opportunities will be more pronounced after 2026, making the conversion of pending proposals a key risk and opportunity.
Catalysts in Upcoming Quarters
Looking forward, the StockStory team will be monitoring (1) the pace at which delayed government contracts are awarded and begin contributing to revenue, (2) adoption rates for new AI-powered tools, especially within Medicaid and SNAP programs, and (3) stabilization or improvement in US Services and international segment volumes. Execution on technology integration and the outcome of pending state legislative changes will also be watched closely for signs of accelerating growth.
Maximus currently trades at $78.00, down from $93.69 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).
Our Favorite Stocks Right Now
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.